Medtronic develops medical therapies for healthcare systems, physicians, and patients globally. The Cardiovascular Portfolio offers implantable devices, cardiac ablation products, and remote monitoring software. The Neuroscience Portfolio provides medical devices, biologic solutions, spinal cord stimulation systems, and interventional products. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, and wound closure products. The Diabetes Operating Unit segment provides insulin pumps, continuous glucose monitoring systems, and smart insulin pen systems. Medtronic was founded in 1949 and is headquartered in Dublin, Ireland.
| Indicator | Value |
|---|---|
| PER | 24.5 |
| EV/EBITDA | 14.3 |
| Price/Free Cash Flow' | 22.1 |
| ROIC | 9.2% |
| Net Debt/EBITDA | 2.7 |